Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study

Larry D. Dillona Larry D. Dillon Surgical Oncology and General Surgery, Colorado Springs, CO, USA

Michael McPheeb Breast Cancer Program, Advent Health Cancer Institute, Orlando, FL, USA

Robert S. Davidsonc Department of Surgical Oncology, Morton Plant Mease Healthcare, FL, USA

Ann P. Quickd Castle Biosciences, Inc, Friendswood, TX, USA

Brian Martind Castle Biosciences, Inc, Friendswood, TX, USA

Kyle R. Covingtond Castle Biosciences, Inc, Friendswood, TX, USA

Olga Zolochevskad Castle Biosciences, Inc, Friendswood, TX, USA

Robert W. Cookd Castle Biosciences, Inc, Friendswood, TX, USACorrespondence[email protected]

John T. Vettoe Department of Neurology, Surgical Oncology, Oregon Health & Science University, Portland, OR, USA

Abel D. Jarellf Department of Dermatology, Northeast Dermatology Associates, P.C., Portsmouth, NH, USA

Martin D. Flemingg Department of Surgical Oncology, The University of Tennessee Health Science Center, Memphis, TN, USA

Your download is now in progress and you may close this window